NIH Chemical Genomics Center, National Institutes of Health, Bethesda, MD 20892-3370, USA.
Toxicol Appl Pharmacol. 2011 May 1;252(3):250-8. doi: 10.1016/j.taap.2011.02.016. Epub 2011 Feb 26.
The human ether-a-go-go-related gene (hERG) channel, a member of a family of voltage-gated potassium (K(+)) channels, plays a critical role in the repolarization of the cardiac action potential. The reduction of hERG channel activity as a result of adverse drug effects or genetic mutations may cause QT interval prolongation and potentially leads to acquired long QT syndrome. Thus, screening for hERG channel activity is important in drug development. Cardiotoxicity associated with the inhibition of hERG channels by environmental chemicals is also a public health concern. To assess the inhibitory effects of environmental chemicals on hERG channel function, we screened the National Toxicology Program (NTP) collection of 1408 compounds by measuring thallium influx into cells through hERG channels. Seventeen compounds with hERG channel inhibition were identified with IC(50) potencies ranging from 0.26 to 22μM. Twelve of these compounds were confirmed as hERG channel blockers in an automated whole cell patch clamp experiment. In addition, we investigated the structure-activity relationship of seven compounds belonging to the quaternary ammonium compound (QAC) series on hERG channel inhibition. Among four active QAC compounds, tetra-n-octylammonium bromide was the most potent with an IC(50) value of 260nM in the thallium influx assay and 80nM in the patch clamp assay. The potency of this class of hERG channel inhibitors appears to depend on the number and length of their aliphatic side-chains surrounding the charged nitrogen. Profiling environmental compound libraries for hERG channel inhibition provides information useful in prioritizing these compounds for cardiotoxicity assessment in vivo.
人类 ether-a-go-go 相关基因(hERG)通道是电压门控钾(K(+))通道家族的一员,在心脏动作电位复极化中发挥着关键作用。由于药物不良反应或基因突变导致 hERG 通道活性降低,可能导致 QT 间期延长,并可能导致获得性长 QT 综合征。因此,在药物开发中筛选 hERG 通道活性非常重要。环境化学物质抑制 hERG 通道引起的心脏毒性也是公共卫生关注的问题。为了评估环境化学物质对 hERG 通道功能的抑制作用,我们通过测量铊通过 hERG 通道流入细胞来筛选国家毒理学计划(NTP)的 1408 种化合物库。鉴定出 17 种具有 hERG 通道抑制作用的化合物,其 IC(50)效力范围为 0.26 至 22μM。其中 12 种化合物在自动全细胞贴附式膜片钳实验中被确认为 hERG 通道阻断剂。此外,我们还研究了属于季铵化合物(QAC)系列的七种化合物对 hERG 通道抑制的构效关系。在四种活性 QAC 化合物中,四正辛基溴化铵在铊内流测定中最有效,IC(50)值为 260nM,在膜片钳测定中为 80nM。这一类 hERG 通道抑制剂的效力似乎取决于其带电荷氮周围脂肪侧链的数量和长度。对环境化合物库进行 hERG 通道抑制筛选,可以为这些化合物进行体内心脏毒性评估提供有用的信息。